Company Filing History:
Years Active: 2015-2019
Title: The Innovations of Tom Nathan McNeilly
Introduction
Tom Nathan McNeilly, a notable inventor from Midlothian, GB, has made significant contributions to the field of immunology. With a total of two patents, his work focuses on developing immunogenic compositions aimed at combating infections from harmful bacteria.
Latest Patents
McNeilly's latest patents include "Immunogenic compositions containing H7 flagella and methods of use thereof" and a related patent, "Immunogenic compositions containing O157:H7 flagella including fusion proteins and methods using the immunogenic compositions." These inventions detail methods for inducing an immune response in animals to the O157:H7 flagella, which can prevent colonization and reduce infection rates. His innovations promise to significantly impact veterinary medicine by enhancing animal health through improved immune responses.
Career Highlights
Throughout his career, McNeilly has demonstrated a commitment to research and innovation. His work has primarily taken place at esteemed organizations such as The University of Edinburgh and Moredun Research Institute. His experience and knowledge in microbiology and immunology have shaped his inventions, which address critical health issues.
Collaborations
In his quest to develop new immunogenic solutions, McNeilly has collaborated with notable academics, including David Gally and David George Emslie Smith. These partnerships have provided a rich environment for innovation and research advancement, leading to the successful development of his patented technologies.
Conclusion
Tom Nathan McNeilly represents the spirit of innovation, using his expertise to tackle significant health challenges faced by animals. With his groundbreaking patents, he is paving the way for advancements in immunology, making a lasting impact on the field and enhancing animal welfare. His legacy serves as an inspiration for upcoming inventors and researchers dedicated to making the world a healthier place.